HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹27 Cr | ₹19 Cr | ₹27 Cr | ₹39 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of HESTER BIOSCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹34 Cr |
How is Consolidated Net Profit of HESTER BIOSCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 45.52 | |
| Mar2025 | ₹19 Cr | -29.06 | |
| Mar2024 | ₹27 Cr | -32.28 | |
| Mar2023 | ₹39 Cr | 14.20 | |
| Mar2022 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,890.2 Cr | 3.4% | 1.8% | 23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 3.4% |
1.8% |
23.7% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses